Loomis, Sayles & Company
MDXG icon

Loomis, Sayles & Company’s MiMedx Group MDXG Stock Holding History

Loomis, Sayles & Company’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-500
Closed -$7K – 956
2017
Q2 		$7K Buy
500
+148
+42% +$1.98K ﹤0.01% 832
2017
Q1 		$3K Hold
352
– – ﹤0.01% 907
2016
Q4 		$3K Hold
352
– – ﹤0.01% 953
2016
Q3 		$3K Hold
352
– – ﹤0.01% 939
2016
Q2 		$3K Hold
352
– – ﹤0.01% 923
2016
Q1 		$3K Buy
+352
New +$2.92K ﹤0.01% 981
2015
Q4 		– Sell
-1,541,477
Closed -$14.9M – 1090
2015
Q3 		$14.9M Buy
1,541,477
+7,114
+0.5% +$75.1K 0.04% 359
2015
Q2 		$17.8M Buy
+1,534,363
New +$15.8M 0.05% 360
2015
Q1 		– Sell
-8,188
Closed -$94K – 755
2014
Q4 		$94K Sell
8,188
-39
-0.5% -$385 ﹤0.01% 672
2014
Q3 		$59K Buy
8,227
+1,233
+18% +$8.6K ﹤0.01% 690
2014
Q2 		$50K Sell
6,994
-98
-1% -$574 ﹤0.01% 721
2014
Q1 		$43K Buy
+7,092
New +$52.1K ﹤0.01% 708

Other funds holding MDXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Loomis, Sayles & Company's MDXG Position: Q3 2017 in Review

Loomis, Sayles & Company sold out of MiMedx Group (MDXG) in Q3 2017, closing a stake of 500 shares — an estimated $7K sold.

Loomis, Sayles & Company first reported a position in MDXG in Q1 2014 and held it in 12 quarters. The position peaked at $17.8M in Q2 2015. 232 funds tracked by Wall St. Rank hold MDXG as of Q3 2017.

  • Loomis, Sayles & Company reported no remaining MiMedx Group position as of Q3 2017 after selling out during the quarter.
  • Loomis, Sayles & Company sold 500 MiMedx Group shares in Q3 2017, an estimated $7K.
  • Loomis, Sayles & Company first reported a position in MiMedx Group in Q1 2014 and held it in 12 quarters.
  • Loomis, Sayles & Company's MiMedx Group position peaked at $17.8M in Q2 2015.
  • 232 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2017.

Based on Loomis, Sayles & Company's 13F filing for Q3 2017, filed 14 Nov 2017.